University of Arizona

Other

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

176

Clinical Trials↗

All sponsored trials (all statuses)

Pipeline

Pipeline Snapshot

By Phase

12 drugs in development

Approved2

Phase 32

Phase 24

Phase 14

Preclinical3

By Therapeutic Area

top 6

Oncology

424%

Respiratory

212%

Neurology

212%

Gastroenterology

16%

Cardiovascular

16%

Psychiatry

16%

R&D Momentum

75/100

Pipeline Velocity

46/100

Trial Completion Rate

69/100

Pipeline Concentration

18/100

Pipeline Freshness

65/100

Strategic Signals

↗Active in Gastroenterology but thin pipeline — potential licensing opportunity

Activity

Recent Activity

Last 14 days

Sep 19, 2026

Recruiting

GLP-1 Receptor Agonist Plus SOC Treatment in First-line, Metastatic Pancreatic, Colorectal, or Hepatocellular Cancer

Sep 12, 2026

Active, not recruiting

Phase II Trial Evaluating the Safety and Efficacy of Atezolizumab in Combination With Cabozantinib for the Treatment of Metastatic, Refractory Pancreatic Cancer

Earlier

Sep 5, 2026TrialMulti-site, Longitudinal Trial Evaluating the Efficacy, Mechanisms, and Moderators of Service Dogs for Military Veterans With PTSD

Sep 4, 2026TrialEndotype DIrected Treatment for OSA in Down Syndrome

Sep 3, 2026TrialM4OC-Prevent 2.0: Phase IIb Trial of Metformin for Oral Cancer Prevention

Aug 15, 2026TrialRadiographic Findings and Clinical Outcomes After Bone Grafting Patellar Defect in ACL Reconstruction

Aug 12, 2026TrialA Randomized, Double-blind, Placebo Controlled Study of the Safety and Efficacy of Angiotensin (1-7) in Persons With Moderate to Severe Traumatic Brain Injury (TBI)

Aug 12, 2026TrialCOVID-19 and University Re-entry/Reopening Strategies-- Addressing the Needs of Older Adults Using a Mixed Methods Approach.

4 more events

Aug 1, 2026TrialSymptom Management and Lifestyle Intervention With Hispanic Cancer Survivors and Caregivers

Aug 1, 2026TrialAdaptive Symptom Self-Management to Reduce Psychological Distress and Improve Symptom Management for Survivors on Immune Checkpoint Inhibitors

Aug 1, 2026TrialImproving Hypertension Medication Adherence for Older Adults

Jul 31, 2026TrialNeuroimaging Study of Fear Learning: Effects of Estrogen

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Pipeline

Drug Pipeline

Therapeutic Area

Preclinical

Phase 1

Phase 2

Phase 3

Approved

Cardiovascular(1 drug)

—

Cardiovascular(1 drug)

Gastroenterology(1 drug)

—

Gastroenterology(1 drug)

Metabolic & Endocrine(1 drug)

—

Metabolic & Endocrine(1 drug)

Neurology(2 drugs)

—

Neurology(2 drugs)

Oncology(4 drugs)

—

Oncology(4 drugs)

Psychiatry(1 drug)

—

Psychiatry(1 drug)

Respiratory(2 drugs)

—

Respiratory(2 drugs)

Unknown / Other(5 drugs)

—

Unknown / Other(5 drugs)

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)